You just read:

Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Markets to 2022 - How Will Immunotherapies Such as Keytruda Contribute to the 8.7% Growth? - Research and Markets

News provided by

Research and Markets

Jun 02, 2016, 06:10 ET